MCLEOD HEALTH CHERAW — History
CCN 420107 | 3-year financial timeline | COVID resilience: 80/100
🛡️ Public data only — no PHI permitted on this instance.
$55M
Latest Revenue (FY2022)
+15.9%
Revenue CAGR (3yr)
1.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $41M | $54M | $55M | +1.3% | +15.9% |
| Operating Expenses | $46M | $57M | $54M | -5.4% | +9.0% |
| Operating Margin | -11.7% | -5.9% | 1.1% | +119.2% | +0.0% |
| Net Income | $-5M | $-3M | $1M | +119.4% | +0.0% |
| Licensed Beds | 48 | 46 | 46 | +0.0% | -2.1% |
| Total Patient Days | 9,718 | 8,716 | 8,351 | -4.2% | -7.3% |
| Medicare Day % | 47% | 44% | 35% | -20.3% | -13.0% |
| Medicaid Day % | 3% | 3% | 7% | +119.1% | +37.8% |
COVID Impact & Recovery
Resilience Score: 80/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +34.3% ($41M → $55M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+15.9%
This Hospital
+7.6%
State Avg
Latest Margin
1.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $62M | 7.5% |
| FY2024 (proj) | $69M | 13.9% |
| FY2025 (proj) | $76M | 20.4% |